Will the U.S. adopt global reference pricing?

This article was written for Med Ad News Magazine

There are many things that Americans get from outside our U.S. borders. Our top imports include oil, machines, and cars; our iTunes and Spotify accounts are stocked with The Beatles, U2, and Ed Sheeran; and you practically can’t go to any city in America without being able to order a pizza, tacos, or sushi.

Although it is true that our country has adopted many things that have improved our lives from outside the U.S., one thing we have not made efforts to adopt is how pharmaceutical drugs are priced outside of the U.S. – that is, until now.

 

Read the full article on the Med Ad News Magazine website.

Author
Matthew Pakizegee
Matthew Pakizegee, PharmD
Medical Associate, Government Policy Systems, Managed Markets

Matthew supports clinical services and leads clinical content for Government Policy Systems (GPS). He facilitates discussions with EVERSANA’s bench of payer consultants and manages government policy content including topics impacting healthcare delivery systems. He has held a variety of roles in biopharma, some of which include landscape analyses in oncology, advisory boards for respiratory and […]

Author
Lauren Pegas
Lauren Pegas
Vice President, Senior Oncology Strategist

Lauren is a pharmaceutical marketing professional with 2 decades of experience on both the client and agency sides. Lauren joined the managed markets team in 2016 and is the lead strategist across 4 oncology/above-brand franchises for a leading U.S. pharmaceutical company. Prior to this, Lauren served as global marketing director for an immuno-oncology blockbuster, where […]